Recurrent Neoplastic Post-Transplant Lymphoproliferative Disorder
Drug | Drug Name | Drug Description |
---|
Drug | Drug Name | Target | Type |
---|
Drug | Drug Name | Phase | Status | Count |
---|---|---|---|---|
DB16222 | Loncastuximab tesirine | 2 | Recruiting | 1 |
Drug | Drug Name | Drug Description |
---|
Drug | Drug Name | Target | Type |
---|
Drug | Drug Name | Phase | Status | Count |
---|---|---|---|---|
DB16222 | Loncastuximab tesirine | 2 | Recruiting | 1 |